Sandbox: m: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 30: | Line 30: | ||
:*A rapid [[lymphocyte]] doubling time is associated with a worse prognosis. | :*A rapid [[lymphocyte]] doubling time is associated with a worse prognosis. | ||
|} | |||
{| style="cellpadding=0; cellspacing= 0; width: 150px;"align=left"; | |||
|- | |||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 20%" align=center |'''Myxoma''' | |||
|- | |||
|style="font-size: 100; padding: 0 5px; background: #FFFFFF" align=center |'''General aspects''' | |||
Isolated cells with irregular cellular borders, mild or no atypia, no mitosis | |||
|- | |||
|style="font-size: 100; padding: 0 5px; background: #FFFFFF" align=center |'''Gross pathology''' | |||
Smooth, lobulated mass can be friable or gelatinous | |||
|- | |||
|style="font-size: 100; padding: 0 5px; background: #FFFFFF" align=center |'''Vascular pattern''' | |||
Perivascular structures | |||
|- | |||
|style="font-size: 100; padding: 0 5px; background: #FFFFFF" align=center |'''Inmunohistochemistry''' | |||
Vimentin, endothelial and neural markers | |||
|- | |||
|style="font-size: 100; padding: 0 5px; background: #FFFFFF" align=center |'''Others''' | |||
Inflammatory infiltrate with hemosiderin,calcifications and extramedullary hemopoyesis. | |||
|- | |||
|} | |} |
Revision as of 23:56, 23 November 2015
Features | Description |
---|---|
General aspects |
|
Genetics |
|
Gross Pathology |
|
Micropathology |
|
Inmunohistochemistry |
|
Myxoma |
General aspects
Isolated cells with irregular cellular borders, mild or no atypia, no mitosis |
Gross pathology
Smooth, lobulated mass can be friable or gelatinous |
Vascular pattern
Perivascular structures |
Inmunohistochemistry
Vimentin, endothelial and neural markers |
Others
Inflammatory infiltrate with hemosiderin,calcifications and extramedullary hemopoyesis. |